You have no items in your shopping cart.
IL-2 Antibody
Description
Images & Validation
−| Tested Applications | ELISA, WB |
|---|---|
| Dilution Range | ELISA: 1:20,000, WB: 1:500-1:2,000 |
| Reactivity | Feline |
| Application Notes |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Immunogen | This protein A purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a recombinant protein raised in yeast corresponding to 134 amino acids of mature cat IL-2. |
| Purity | This product was protein A purified from monospecific antiserum by chromatography. This antibody is specific for cat IL-2 protein. A BLAST analysis was used to suggest cross-reactivity with IL-2 from cat based on 100% homology; cross-reactivity with Northern elephant seal and gray seal based on 90% homology with the immunizing sequence. Cross-reactivity with IL-2 from other sources has not been determined. |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Store vial at -20° C or below prior to opening. This vial contains a relatively low volume of reagent (25 µL). To minimize loss of volume dilute 1:10 by adding 225 µL of the buffer stated above directly to the vial. Recap, mix thoroughly and briefly centrifuge to collect the volume at the bottom of the vial. Use this intermediate dilution when calculating final dilutions as recommended below. Store the vial at -20°C or below after dilution. Avoid cycles of freezing and thawing. |
|---|---|
| Form/Appearance | Liquid (sterile filtered) |
| Buffer/Preservatives | Preservative: 0.01% (w/v) Sodium Azide. Stabilizer: None; Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
| Concentration | 1.15 mg/mL |
| Expiration Date | 12 months from date of receipt. |
| Dry Ice Shipping | Please note: This product requires shipment on dry ice. A dry ice surcharge will apply. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−PD-L1 Antibody / B7-H1 / CD274 [orb2641418]
ELISA, FACS, IF, IHC-P, WB
Human, Mouse
Mouse
Monoclonal
Unconjugated
100 μgPD-L1 Antibody / B7-H1 / CD274 [orb606675]
ELISA, FACS, IF, IHC-P, WB
Human, Mouse
Mouse
Monoclonal
Unconjugated
100 μg, 20 μgZEB1/NIL2A Rabbit Polyclonal Antibody [orb6954]
FC, IF, IHC-Fr, IHC-P, WB
Bovine, Canine, Gallus, Porcine, Rabbit
Human, Mouse, Rat
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl, 200 μlAnti-IL-2R alpha (CD25) [Basiliximab] [orb1152522]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mgAnti-IL-2R alpha (CD25) [Basiliximab] [orb348865]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Western blot using Biorbyt's protein-A purified anti-Cat IL-2 antibody shows detection of recombinant Cat IL-2 at 15.4 kDa, raised in yeast. Primary antibody was diluted to 1 µg/ml. 3% BSA from Biorbyt's Bovine Serum Albumin Solution was used for blocking. Secondary antibody (Goat anti-Rabbit IgG IRDye® 800) was used at 1:20000.
Quick Database Links
UniProt Details
−NCBI Reference Sequences
−| Protein | NP_001036802.1 |
|---|
Documents Download
Request a Document
Protocol Information
IL-2 Antibody (orb345093)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review



























![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_6.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_6.png)